Navigation Links
Rosetta Genomics Announces Presence at ASCO 2013
Date:5/28/2013

PHILADELPHIA and REHOVOT, Israel, May 28, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company will have a significant presence at the upcoming American Society of Clinical Oncologists Annual Meeting (ASCO 2013) taking place at the McCormick Convention Center in Chicago from May 31-June 4, 2013. 

Rosetta Genomics' Cancer Testing Services will be highlighted in an "Industry Expert Theater Presentation," which is a series of hour-long presentations from industry leaders sharing the latest in oncology practices, products, services and technologies*.  Kenneth A. Berlin , Rosetta Genomics' President and Chief Executive Officer, and E. Robert Wassman , MD, FAAP, FACMG, Rosetta Genomics' Chief Medical Officer, will deliver a presentation entitled, "Application of microRNAs in Oncology Diagnostics," on Saturday, June 1st at 3:00 p.m. in the Oncology Professionals Hall. During this presentation, Dr. Wassman will showcase the Rosetta Cancer Origin Test (formally miRview® mets2) featuring case studies of patients with Cancer of Unknown or Uncertain Primary (CUP) impacted by test results, and data from extensive validation studies utilizing samples from real CUP patients, which demonstrated a high level of concordance with the predictions made by leading CUP centers.  

"I am excited to have the opportunity to reinforce the fact that, for physicians, patients, and their families, a diagnosis of Cancer of Unknown Primary in many cases is no longer acceptable. It is not a matter of whether to use microRNA profiling, but when to use it," added Dr. Wassman.

The Compa
'/>"/>

SOURCE Rosetta Genomics Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics Reaches Settlement Agreement with Sanra Laboratories in Connection with Previous Sale of Parkway Clinical Laboratories
2. Rosetta Genomics Announces Poster Presentations at AACR Annual Meeting 2013
3. Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations
4. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
5. Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares
6. Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets
7. Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma
8. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
9. J. Craig Venter Institutes Mobile Genomics Lab Launches First School Visits in San Diego County
10. Real Time Genomics Secures a $5 Million Round of Funding to Expand Commercial Operations
11. Real Time Genomics and Knome Ink Deal to Integrate and Sell the RTG Variant Platform on knoSYS100 System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... December 16, 2014 “Never say, ... Philipps- Universität Marburg’s Department of Physics, advises young ... the newly released SPIE Women in Optics ... too shy to ask questions.” , In the ... and mathematics) occupations ranging from university professor and ...
(Date:12/17/2014)... Long Beach, CA (PRWEB) December 17, 2014 ... Technology, Inc. to provide a larger packaged waste water ... district in King Abdullah Economic City (KAEC). Two years ... for EMAAR’s Jeddah Gate Development, serving two residential towers ... plant capacity is over a quarter million gallons per ...
(Date:12/17/2014)... Gene synthesis and bioengineering company ... into a technology access and services agreement with ... proprietary protein engineering technology, known as “ProteinGPS®” to ... extremely excited that the global leader ADM has ... bioengineering technology has now been validated through many ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2
... July 8 iZumi Bio, Inc. and Pierian, Inc. ... company, iPierian, Inc. Building on the iZumi infrastructure and ... cellular reprogramming to change the paradigm of drug discovery. ... development of new therapeutics using induced pluripotent stem (iPS) ...
... TREK Diagnostic Systems, a Magellan Biosciences business and premier ... labs, has received clearance from the U.S. Food and ... of YeastOne susceptibility products. TREK will make the drug ... the plate that best meets their requirements. The custom ...
... Immunotec Receives NHPD/Health Canada Authorization to Begin a Study on, ... Isolate (Immunocal(R)) in, Combination with Physical Exercise ... Cytokine Levels in Elderly Persons: A Randomized, ... Immunotec Inc. (TSX-V: IMM) announced today that the Natural Health ...
Cached Biology Technology:iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 2iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 3iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 4iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 5iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming 6FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line 2FDA Clears Caspofungin (Cancidas(R)) Susceptibility Testing for TREK Sensititre(R) YeastOne(R) in Vitro Diagnostics (IVD) Product Line 32009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process 22009: Immunotec announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process 3
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a ... while. Hypertension – the medical term for high blood pressure ... 1800s, and the inflatable cuff that,s used in measuring blood ... mean there,s nothing new about hypertension, its triggers and its ... about the condition and the best ways to treat it. ...
(Date:12/10/2014)... Forest Baptist Medical Center today announced plans for a ... Funding for this $50 million capital project is part ... launched next summer. The medical education ... R.J. Reynolds Tobacco Company complex, adjacent to 525@vine in ... plans to be ready to welcome medical students in ...
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4
... dominant natural process of new species formation and trigger ... in the journal PLoS ONE . The ... to 375 million years ago suggests that the planet,s ... meet a similar fate. Although Earth has experienced ...
... significant problem on highway embankments in New England. To ... with a grasslegume mixture that usually including red fescue, ... thrive in acidic, infertile soil. "A mixture of red ... stabilize the soil, but only the red fescue survives ...
... EL PASO, TX To conserve dwindling water ... municipal wastewater that has been extensively treated and deemed ... recycled water can be cost-effective and helps conserve the ... of bedding plants means income and jobs, commercial growers ...
Cached Biology News:What triggers mass extinctions? Study shows how invasive species stop new life 2What triggers mass extinctions? Study shows how invasive species stop new life 3Researchers discover potential solutions to New England roadside erosion 2Can bedding plants thrive with recyled water? 2